Skip to main content

H.R. 3172

Referred to Committee

Medicare IVIG Demonstration Extension Act of 2017

Introduced 7/10/2017•115th Congress•House

Latest Action

Referred to the Subcommittee on Health.

7/20/2017 • House

Summary

Medicare IVIG Demonstration Extension Act of 2017

This bill amends the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 to extend the Medicare Intravenous Immune Globulin (IVIG) demonstration project through 2020, subject to the availability of funds. (This demonstration project provides for bundled Medicare payments with respect to certain items and services that are necessary to administer IVIG in the home.) A Medicare beneficiary who is enrolled in the project on September 30, 2017, shall be automatically reenrolled, subject to an existing cap on project participants.

Introduced in House • 7/10/2017

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Drug therapyHealth technology, devices, suppliesHome and outpatient careImmunology and vaccinationMedicare

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (3)

Party Breakdown

2
Democrats
1
Republicans
0
Independents

Sponsor

R[
Rep. Brady, Kevin [R-TX-8]

Republican • TX-8

Sponsored 7/10/2017

Cosponsors (2)

R[
Rep. Matsui, Doris O. [D-CA-6]

D-CA-6

Joined 7/10/2017

R[
Rep. Walz, Timothy J. [D-MN-1]

D-MN-1

Joined 1/12/2018

Bill Journey

Originated in the House

Introduced

July 10, 2017

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House7/10/2017

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors2